Michael Helmrath · Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents
Follow
Article1 min read·Published Nov 2015Older

Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Nov 2015 · 1 min read

In brief

In brief

This prospective multicenter study of 242 adolescents demonstrates sustained weight loss (27% mean reduction) and high remission rates of obesity-related comorbidities including type 2 diabetes (95%) and abnormal kidney function (86%) at 3 years following Roux-en-Y gastric bypass or sleeve gastrectomy.

Written by the GCMD Library team from the article.

Michael Helmrath

Background: Bariatric surgery is increasingly considered for the treatment of adolescents with severe obesity, but few prospective adolescent-specific studies examining the efficacy and safety of weight-loss surgery are available to support clinical decision making. Methods: We prospectively enrolled 242 adolescents undergoing weight-loss surgery at five U.S. centers. Patients undergoing Roux-en-Y gastric bypass (161 participants) or sleeve gastrectomy (67) were included in the analysis. Changes in body weight, coexisting conditions, cardiometabolic risk factors, and weight-related quality of life and postoperative complications were evaluated through 3 years after the procedure. Results: The mean (±SD) baseline age of the participants was 17±1.6 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 53; 75% of the participants were female, and 72% were white. At 3 years after the procedure, the mean weight had decreased by 27% (95% confidence interval [CI], 25 to 29) in the total cohort, by 28% (95% CI, 25 to 30) among participants who underwent gastric bypass, and by 26% (95% CI, 22 to 30) among those who underwent sleeve gastrectomy. By 3 years after the procedure, remission of type 2 diabetes occurred in 95% (95% CI, 85 to 100) of participants who had had the condition at baseline, remission of abnormal kidney function occurred in 86% (95% CI, 72 to 100), remission of prediabetes in 76% (95% CI, 56 to 97), remission

Statements in this article

  1. The study enrolled 242 adolescents undergoing weight-loss surgery at five U.S. centers, with 161 undergoing Roux-en-Y gastric bypass and 67 undergoing sleeve gastrectomy.

    ResearchMethods
  2. The mean baseline age of participants was 17±1.6 years, mean body-mass index was 53, 75% were female, and 72% were white.

    ResearchResults
  3. At 3 years after bariatric surgery, mean weight decreased by 27% (95% CI, 25 to 29) in the total cohort.

    ResearchResults
  4. At 3 years, participants who underwent gastric bypass had a mean weight decrease of 28% (95% CI, 25 to 30).

    ResearchResults
  5. At 3 years, participants who underwent sleeve gastrectomy had a mean weight decrease of 26% (95% CI, 22 to 30).

    ResearchResults
  6. Remission of type 2 diabetes occurred in 95% (95% CI, 85 to 100) of participants who had the condition at baseline by 3 years after the procedure.

    ResearchResults
  7. Remission of abnormal kidney function occurred in 86% (95% CI, 72 to 100) of affected participants by 3 years after the procedure.

    ResearchResults
  8. Remission of prediabetes occurred in 76% (95% CI, 56 to 97) of affected participants by 3 years after the procedure.

    ResearchResults

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →